- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03416842
Home Exercise With Wearable Sensors
July 9, 2019 updated by: Burke Medical Research Institute
Home-based Exercises Using Wearable Motion Sensors for Community-dwelling Stroke Survivors With Hemiparesis
Repetitious motor therapy has been shown to yield the greatest improvement in motor function in those who suffer hemiplegia because of a neurological impairment.
However, motor therapy remains largely clinically based due to the absence of quantitative home-based therapy technology or equipment.
With the current lack of accountability, patient adherence to home exercise physical therapy programs is estimated to be as low as 35%.
In response, some companies have extended the applications of their motion capture devices to be used for home-based physical therapy.
However, the technologies often have not passed their initial stages of development.
In contrast, a company named 4D Motion is actively working alongside the Restorative Neurology Clinic at Burke Medical Research Institute to develop a motion capture system tailored to the motor rehabilitation of hemiplegic stroke patients.
This device is driven by a user's active range of motion and does not impart electrical or mechanical stimulation to the user.
The device does not force the user beyond their active range of motion and does not apply resistance to motion that limits the user's capability.
The 4D Motion capture system is only used to record what the patient is doing and to promote adherence to their prescribed physical therapy plan.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
6
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
White Plains, New York, United States, 10605
- Burke Medical Research Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Able to follow 1-2 step commands
- Neurological deficit leading to hemiparesis or hemiplegia with a sensorimotor deficit
- Fugl Meyer Upper Extremity Score of at least 20/66
Exclusion Criteria:
- Has a metal implant anywhere on or inside the body
- Fixed contracture or deformity of affected upper extremity
- Individuals with bilateral stroke (i.e. if both arms are affected)
- Unable to tolerate repetitious movement as determined by Likert Scale Rating greater than 5 out of 10
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DEVICE_FEASIBILITY
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Training with 4D Motion Capture Device
Participants will be given access to a tablet-based application and non-invasive sensors that will track movements of the upper extremity and will prompt daily exercise.
Participants will be encouraged to use the device daily for 30 consecutive days, up to one hour per day.
|
Participants will be given access to a tablet-based application and non-invasive sensors that will track movements of the upper extremity and will prompt daily exercise.
Participants will be encouraged to use the device daily for 30 consecutive days, up to one hour per day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of treatment days completed
Time Frame: From day 1 to day 30 of intervention
|
Measure of the number of days that the participant adheres to the prescribed therapy plan (completion of 1000 movements).
Goal is to have participants perform 1000 movements per day over 30 days.
|
From day 1 to day 30 of intervention
|
|
Change in active range of motion of shoulder, elbow, and wrist
Time Frame: From day 1 to day 30 of intervention
|
Maximum angular position about a joint that the participant can reach without assistance.
|
From day 1 to day 30 of intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Fugl Meyer upper extremity assessment
Time Frame: From day 1 to day 30 of intervention
|
Clinical scale that measures upper extremity impairment in stroke patients
|
From day 1 to day 30 of intervention
|
|
Physical Activity Enjoyment Scale
Time Frame: Day 30 of intervention
|
Survey of how well a participant enjoyed the study treatment.
|
Day 30 of intervention
|
|
System usability survey
Time Frame: Day 30 of intervention
|
Survey of user-friendliness of software and device
|
Day 30 of intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 1, 2018
Primary Completion (ACTUAL)
June 27, 2018
Study Completion (ACTUAL)
December 31, 2018
Study Registration Dates
First Submitted
January 18, 2018
First Submitted That Met QC Criteria
January 24, 2018
First Posted (ACTUAL)
January 31, 2018
Study Record Updates
Last Update Posted (ACTUAL)
July 10, 2019
Last Update Submitted That Met QC Criteria
July 9, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BRC559
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Training with 4D Motion Capture Device
-
Istituto Ortopedico RizzoliIsokineticCompletedAnterior Cruciate Ligament Injury | Sport Injury | Biomechanical; LesionItaly
-
National Yang Ming Chiao Tung UniversityNot yet recruitingUnilateral Transfemoral Amputation | Unilateral Knee DisarticulationTaiwan
-
The Children's Hospital of Zhejiang University...Not yet recruitingRandomized Controlled Trial | Extracorporeal Shock Wave Lithotripsy | Pediatric Urolithiasis | Optical Motion Capture | Ultrasound Localization | Localization EfficiencyChina
-
Shirley Ryan AbilityLabActive, not recruitingStroke | HealthyUnited States
-
Evolucare TechnologiesAssistance Publique - Hôpitaux de Paris; Slb Pharma; BPIfranceRecruitingGlaucoma | Age-Related Macular Degeneration | Diabetic Retinopathy | Diabetic Macular Edema | Age-related MaculopathyFrance
-
University Hospital, MontpellierNot yet recruitingIdentification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk (TENVOL)Knee Injuries | Jumper's Knee | Patellar Tendinitis | Musculoskeletal InjuriesFrance
-
Swiss Federal Institute of TechnologyUniversity of Zurich; cereneo center for Neurology and RehabilitationRecruitingParkinson Disease | Gait Disorders, NeurologicSwitzerland
-
University of Kansas Medical CenterKurume UniversityCompleted
-
Syracuse UniversityCompleted
-
Federal Center of Cerebrovascular Pathology and...RecruitingStroke | Oculomotor; Disorder | Attention DisturbancesRussian Federation